West Nile virus Grifols ART System Nabs FDA Approval The system is approved for use with the Procleix Ultrio Elite Assay, the Procleix WNV Assay, Procleix Zika Virus Assay, and the Procelix Babesia Assay. Researchers Slam 'Stupendously Unethical' CRISPR Germline Genome Editing Experiments Premium Even as He Jiankui expressed pride in the work he had done to alter the CCR5 genes of twin embryos, researchers and ethicists decried him as misguided. FDA Grants EUA for Columbia University's Zika Test The PCR-based test can simultaneously detect for the Zika virus, all serotypes of the dengue virus, the chikungunya virus, the West Nile virus, and a host gene. Hologic to Divest Stake in Blood Screening Business to Grifols for $1.85B Hologic CEO Steve MacMillan said that the deal is so compelling that the firm needed to do it now. Sandia Researchers Developing Multiplex Assay Differentiating Viral Febrile Illnesses, Malaria Premium The researchers are using an NIH grant to develop a device to discriminate various fever-causing viruses endemic to West Africa and Plasmodium falciparum. Dec 15, 2014 Roche Cobas Assays Get Additional CE Claims for Organ, Tissue Testing Sep 2, 2014 Roche Gets CE Mark for New Molecular Blood Screening Systems Sep 30, 2010 International Team Sequences Genome of West Nile-Transmitting Mosquito Sep 16, 2009 Inviragen Wins Follow-on NIH Grant to Develop Dengue Fever Vaccine with UW-Madison, CDC Premium Sep 9, 2009 Receptor Logic, Texas Tech HSC to Use NCI STTR Cash for Breast Cancer mAb IND Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.